164 related articles for article (PubMed ID: 20027308)
41. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
[TBL] [Abstract][Full Text] [Related]
42. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
Hunter CA; Subauste CS; Van Cleave VH; Remington JS
Infect Immun; 1994 Jul; 62(7):2818-24. PubMed ID: 7911785
[TBL] [Abstract][Full Text] [Related]
43. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
45. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.
Danner R; Chaudhari SN; Rosenberger J; Surls J; Richie TL; Brumeanu TD; Casares S
PLoS One; 2011; 6(5):e19826. PubMed ID: 21611197
[TBL] [Abstract][Full Text] [Related]
46. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
[TBL] [Abstract][Full Text] [Related]
47. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.
Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
Cancer Immunol Immunother; 2013 Aug; 62(8):1359-68. PubMed ID: 23689729
[TBL] [Abstract][Full Text] [Related]
48. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
Condiotti R; Zakai YB; Barak V; Nagler A
Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111
[TBL] [Abstract][Full Text] [Related]
49. A novel dendritic cell subset involved in tumor immunosurveillance.
Taieb J; Chaput N; Ménard C; Apetoh L; Ullrich E; Bonmort M; Péquignot M; Casares N; Terme M; Flament C; Opolon P; Lecluse Y; Métivier D; Tomasello E; Vivier E; Ghiringhelli F; Martin F; Klatzmann D; Poynard T; Tursz T; Raposo G; Yagita H; Ryffel B; Kroemer G; Zitvogel L
Nat Med; 2006 Feb; 12(2):214-9. PubMed ID: 16444265
[TBL] [Abstract][Full Text] [Related]
50. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
Gorantla S; Sneller H; Walters L; Sharp JG; Pirruccello SJ; West JT; Wood C; Dewhurst S; Gendelman HE; Poluektova L
J Virol; 2007 Mar; 81(6):2700-12. PubMed ID: 17182671
[TBL] [Abstract][Full Text] [Related]
51. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
[TBL] [Abstract][Full Text] [Related]
52. Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.
Hattori S; Matsuda K; Kariya R; Harada H; Okada S
Microbiol Immunol; 2016 Feb; 60(2):106-13. PubMed ID: 26708420
[TBL] [Abstract][Full Text] [Related]
53. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
54. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity.
Nishime C; Kawai K; Yamamoto T; Katano I; Monnai M; Goda N; Mizushima T; Suemizu H; Nakamura M; Murata M; Suematsu M; Wakui M
J Immunol; 2015 Aug; 195(4):1883-90. PubMed ID: 26170385
[TBL] [Abstract][Full Text] [Related]
55. The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.
Chieregato K; Zanon C; Castegnaro S; Bernardi M; Amati E; Sella S; Rodeghiero F; Astori G
Blood Transfus; 2017 Jan; 15(1):93-100. PubMed ID: 27136441
[TBL] [Abstract][Full Text] [Related]
56. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
57. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
Arase H; Arase N; Saito T
J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-21 differentially affects human natural killer cell subsets.
Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
[TBL] [Abstract][Full Text] [Related]
59. Humanized mouse model supports development, function, and tissue residency of human natural killer cells.
Herndler-Brandstetter D; Shan L; Yao Y; Stecher C; Plajer V; Lietzenmayer M; Strowig T; de Zoete MR; Palm NW; Chen J; Blish CA; Frleta D; Gurer C; Macdonald LE; Murphy AJ; Yancopoulos GD; Montgomery RR; Flavell RA
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9626-E9634. PubMed ID: 29078283
[TBL] [Abstract][Full Text] [Related]
60. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft.
Zhang J; Sun R; Wei H; Tian Z
Int Immunopharmacol; 2005 Feb; 5(2):417-25. PubMed ID: 15652770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
